ID: ALA1818485

Max Phase: Preclinical

Molecular Formula: C25H19F2N3O4S

Molecular Weight: 495.51

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C1OCC(c2cccs2)=C1c1ccc(OCC(O)(Cn2cncn2)c2ccc(F)cc2F)cc1

Standard InChI:  InChI=1S/C25H19F2N3O4S/c26-17-5-8-20(21(27)10-17)25(32,12-30-15-28-14-29-30)13-34-18-6-3-16(4-7-18)23-19(11-33-24(23)31)22-2-1-9-35-22/h1-10,14-15,32H,11-13H2

Standard InChI Key:  MQEDRJWTHWWQNM-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 495.51

Molecular Weight (Monoisotopic): 495.1064

AlogP: 4.05

#Rotatable Bonds: 8

Polar Surface Area: 86.47

Molecular Species: NEUTRAL

HBA: 8

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 12.24

CX Basic pKa: 2.00

CX LogP: 4.32

CX LogD: 4.32

Aromatic Rings: 4

Heavy Atoms: 35

QED Weighted: 0.37

Np Likeness Score: -0.79

References

1. Borate HB, Sawargave SP, Chavan SP, Chandavarkar MA, Iyer R, Tawte A, Rao D, Deore JV, Kudale AS, Mahajan PS, Kangire GS..  (2011)  Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity.,  21  (16): [PMID:21757344] [10.1016/j.bmcl.2011.06.022]

Source

Source(1):

• Scientific Literature